Your responsibilities will include:
- Perform compensation admin tasks like field LOA, territory & account management
- Execute month end, quarter end and year end commissions, bonuses, and awards to the field sales organization.
- Track and report on Key Performance Indicators related to specific business function
- Utilize available reporting tools and technology to deliver intuitive analyses to the field
- Lead process improvement initiatives for CoE Team
- Partner on cross functional strategic projects as needed
Required qualifications:
- Bachelor’s Degree
- At least 2 years of experience in Sales or Financial Analyst role
- Proven analytical and problem-solving experience
- Strong back office application skills, including expert level Excel, MS Access
- Preferred Anaplan level 1 certification
- Demonstrated ability to balance multiple priorities against strict deadlines while maintaining a high degree of accuracy, attention to detail, and customer service
- Excellent interpersonal skills and above average writing and verbal communication skills to work with individuals at all levels of the organization
- Organization skills and the ability to handle work of a highly confidential nature
- Desire to work in a high paced collaborative, teamwork-oriented environment
- Ability to travel up to 10%.
Please be advised that certain US based positions, including without limitation field sales and service positions that call on hospitals and/or health care centers, require acceptable proof of COVID-19 vaccination status. Candidates will be notified during the interview and selection process if the role(s) for which they have applied require proof of vaccination as a condition of employment. Boston Scientific continues to evaluate its policies and protocols regarding the COVID-19 vaccine and will comply with all applicable state and federal law and healthcare credentialing requirements. As employees of the Company, you will be expected to meet the ongoing requirements for your roles, including any new requirements, should the Company’s policies or protocols change with regard to COVID-19 vaccination.